15:39 PM
After Medarex (MEDX +89%) fetched a healthy premium from Bristol-Myers Squibb (BMY +3.1%), investors have begun looking at similar companies to see who's next up for bids: Regeneron Pharmaceuticals (REGN +8.8%)? Seattle Genetics (SGEN +5.6%)? Alexion (ALXN +7.6%)? Allos Therapeutics (ALTH +6.9%)? Celldex Therapeutics (CLDX +6.7%)? Dendreon (DNDN +6.6%)?
Comment!
08:08 AMAlexion Pharmaceuticals (ALXN): Q2 EPS of $0.20 beats by $0.04. Revenue of $92M (+55%) vs. $89M. Shares +1.9% premarket. (PR)
Comment!
07:01 AM
Big Pharma is feeling the need to find new products with blockbuster potential as important patents expire. Likely buyout targets include AMLN, UTHR, ALXN. ONXX and VRTX, Barron's says.
Comment!